Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

May 12, 2020

Study Completion Date

September 7, 2020

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Celecoxib 200mg

comparator medication

DRUG

Tramadol 37.5Mg+ Celecoxib 200mg

experimental medication

DRUG

Tramadol 75mg+ Celecoxib 200mg

experimental medication

DRUG

Tramadol 150mg+ Celecoxib 200mg

experimental medication

Trial Locations (10)

Unknown

Dong-A University Hospital., Busan

Bundang Seoul University Hospital, Seoul

Gachon University Gil Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyung Hee University Hospital at Gangdong, Seoul

KyungHee University Medical Center, Seoul

Soonchungyand University Hospital, Seoul

The Catholic University of Korea, Seoul ST. Mary's Hospital., Seoul

All Listed Sponsors
collaborator

CliPS Co., Ltd

INDUSTRY

lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT03850587 - Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter